In AS, apelin-13 increases mitophagy by activating the PINK1/Parkin pathway, and F13A is an apelin-13 antagonist in PINK1 and Parkin-dependent mitophagy, which blocks the effect of apelin-13 in the progression of atherosclerosis [190]. This evidence concerns the gene APLN and atherosclerosis.